香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責，對其 準確性或完整性亦不發表任何聲明，並明確表示概不會就因本公告全部或任何部分內容 而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 （於中華人民共和國註冊成立的股份有限公司） （股份代號：00753） 海外市場公告 本公告乃根據香港聯合交易所有限公司證券上市規則第13.10B條的規定而發表。 附件為中國國際航空股份有限公司於上海證券交易所刊發之 中國國際航空股份有限公司第七屆董事會第五次會議決議公告 承董事會命 中國國際航空股份有限公司 聯席公司秘書 肖烽 浩賢 中國北京，二零二五年七月二十九日 於本公告日期，本公司的董事為馬崇賢先生、王明遠先生、崔曉峰先生、Patrick Healy （賀以禮）先生、肖鵬先生、徐念沙先生*、禾雲先生*、譚允芝女士*及高春雷先生*。 * 本公司獨立非執行董事 证券代码：601111 股票简称：中国国航 公告编号：2025-032 中国国际航空股份有限公司 第七届董事会第五次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整 ...

证券代码：601111 股票简称：中国国航 公告编号：2025-033 中国国际航空股份有限公司 关于出售资产暨关联交易的公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 1 交易内容：中国国际航空股份有限公司（以下简称"本公司"或"公司"） 拟向中国国际货运航空股份有限公司（以下简称"国货航"）出售 2 台 Trent700 备用发动机和 1 台 GTCP331-350C 备用 APU（以下简称"本次交易"或"本 次关联交易"），出售价格为人民币 15,144.05 万元（不含税）。本次交易 已经公司第七届董事会第五次会议审议通过。 国货航系本公司控股股东中国航空集团有限公司（以下简称"中航集团公 司"）间接控制的公司，本次交易构成关联交易，但不构成《上市公司重大 资产重组管理办法》规定的重大资产重组。 至本次关联交易为止，过去 12 个月内公司与同一关联方之间发生的需要与 本次交易进行累计计算的交易总金额未达到公司最近一期经审计净资产绝 对值的 5%。本次关联交易未达到股东会审议标准。 本次交 ...

证券代码：601111 股票简称：中国国航 公告编号：2025-032 中国国际航空股份有限公司 第七届董事会第五次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、董事会会议召开情况 中国国际航空股份有限公司（以下简称"公司"）第七届董事会第五次会议 （以下简称"本次会议"）的通知和材料已于 2025 年 7 月 23 日以电子通讯等方 式发出。本次会议于 2025 年 7 月 29 日 11:00 在北京市顺义区天柱路 30 号国航 总部大楼 C713 会议室以现场结合视频方式召开。本次会议应出席董事 9 人，实 际出席董事 9 人。本次会议由董事长马崇贤先生主持，公司高级管理人员列席本 次会议。本次会议的召集和召开符合《公司法》等相关法律、行政法规、规章、 规范性文件及公司章程的规定，合法、有效。 二、董事会会议审议情况 本次会议审议并通过《关于向国货航转让备用发动机的议案》。 表决情况：赞成 4 票、反对 0 票、弃权 0 票、回避 5 票，表决结果：通过。 本议案已经第七届董事会审计和风险管理委员会（ ...

Group 1: Market Overview - The Hang Seng Index (HSI) is expected to continue rising to 25,800-26,000 next week, with a support level at 24,600 and a resistance level at 25,894 [1] - Technical signals indicate a "strong buy" for the semiconductor sector, with a potential price target of 56-60 HKD for SMIC [3] - China Southern Airlines has recently broken through its previous high, with a key resistance level at 6.19 HKD [6] Group 2: Individual Stock Analysis - Ganfeng Lithium is showing a gradual upward trend, with a support level at 27 HKD and a resistance level at 33.6 HKD, potentially reaching 35 HKD [9] - Alibaba's stock is currently viewed as a buying opportunity, with a target of 130 HKD and support levels at 112.3 HKD and 105.7 HKD [12] - AAC Technologies has a neutral technical signal, with resistance levels at 41.2 HKD and 42.5 HKD, indicating a lack of clear direction [15]

Market Overview - The Hong Kong stock market experienced a decline, with the Hang Seng Index dropping over 1%, ending a five-day winning streak, closing at 25,388.35 points, down 1.09% or 278.83 points, with a total turnover of 281.77 billion HKD [1] - Despite the decline, the Hang Seng Index saw a weekly increase of 2.27%, while the Hang Seng China Enterprises Index and the Hang Seng Tech Index rose by 1.83% and 2.51% respectively [1] Blue Chip Performance - WuXi Biologics (02269) led the blue-chip stocks, rising 5.53% to 31.5 HKD, contributing 9.65 points to the Hang Seng Index, following a profit warning indicating a projected 16% revenue growth in the first half of 2025 [2] - Other notable blue-chip performances included SMIC (00981) up 4.98%, Nongfu Spring (09633) up 3.56%, while New Oriental (09901) and Shenzhou International (02313) saw declines of 3.36% and 2.94% respectively [2] Sector Highlights - Large tech stocks generally declined, with Alibaba down nearly 2% and Tencent over 1% [3] - Semiconductor stocks saw a rally, with Hua Hong Semiconductor rising 9% and SMIC up nearly 5% [3] - The pharmaceutical sector experienced gains, driven by a shift towards value assessment in drug procurement, with notable increases in stocks like Kanglong Chemical (03759) up 7.71% and Zhaoyan New Drug (06127) up 7.02% [4] - Airline stocks were active, with China Eastern Airlines (00670) up 3.69% and Air China (00753) up 3.68%, supported by strong summer travel demand [6][7] Regulatory Developments - The National Healthcare Security Administration announced changes to the 11th batch of centralized procurement, moving away from a simple lowest price reference, which is expected to curb vicious price competition and promote a shift towards value-based competition in the pharmaceutical industry [5] - The introduction of new policies aimed at supporting innovative drugs and medical devices was discussed in a recent meeting, indicating a focus on enhancing the clinical application of high-level technological innovations [5] Notable Stock Movements - Valiant Biopharma (09887) saw a significant increase of 91.71% on its debut, closing at 67.1 HKD, following a successful IPO [9] - Jihong Holdings (02603) rose 15.31% after announcing a projected net profit increase of 97.25% to 108.21% for the first half of 2025 [10] - COSCO Shipping Ports (01199) reached a new high, up 9.31%, amid reports of potential acquisitions of port assets [11] - Kintor Pharmaceutical (00148) announced a profit warning, leading to an 8.29% increase in stock price, with expected profits rising over 70% [12] - Lingbao Gold (03330) also saw gains, up 5.89%, with projected revenue growth of 75% to 85% for the first half of 2025 [13]

消息面上，7月22日，2025年全国民航年中工作电视电话会议在京召开，民航局局长宋志勇在会议强 调，优化航线网络布局，积极服务扩大内需和对外开放；加快构建民航领域统一大市场，综合整治行 业"内卷式"竞争。此前6月26日，民航局已召开电话会，专题部署民航领域综合整治"内卷式"竞争工 作。此外，据信达证券，7.1-7.22暑运累计旅客量吞吐量9986.4万人次，同比增加3.0%；航班执行量69.1 万架次，同比增加2.5%；国内线客座率84.3%，累计同比增加1.0pct，客座率持续高位。境内航线平均 票价同比减少7.8%，单位座收同比减少7.6%。 信达证券认为，民航局专题部署民航领域综合整治"内卷式"竞争工作，引导行业回归理性竞争、有序发 展，格局有望持续改善。暑运旺季需求持续增长、客座率高位，供需或将改善，有望带动座收回升。看 好座收回升带来的航司利润弹性。国泰海通证券指出，2025年以来，航空供需持续向好，且4-5月航司 收益管理策略初现改善。"反内卷"将减少过度低价，助力收益管理继续改善，加速行业盈利恢复与中枢 上行。同时，"反内卷"有望保障未来行业机队规划继续低速增长。 智通财经APP获悉，航空股表现 ...

Core Viewpoint - The aviation sector in Hong Kong and mainland China is experiencing a positive performance, with significant stock price increases for major airlines, while the industry is also addressing challenges related to competition and profitability [1][5][6]. Group 1: Stock Performance - Hong Kong aviation stocks showed active performance, with China National Aviation rising by 6.25%, China Southern Airlines and China Eastern Airlines increasing by over 3%, and Cathay Pacific rising by 0.17% [1]. - In the A-share market, Huaxia Airlines rose over 4%, while China National Aviation and Juneyao Airlines increased by over 3% [2]. Group 2: Industry Developments - The Civil Aviation Administration of China (CAAC) held a meeting on July 22, 2025, outlining nine requirements to enhance the aviation sector, including the establishment of a unified market and addressing "involution" competition [3][4]. - In the first half of the year, the aviation industry achieved a total transport turnover of 783.5 billion ton-kilometers and a passenger transport volume of 37 million, marking year-on-year growth of 11.4% and 6% respectively [3]. Group 3: Financial Performance of Airlines - Major state-owned airlines are expected to report significant losses for the first half of 2025, with China Eastern Airlines projecting a net loss of 1.2 to 1.6 billion yuan, China Southern Airlines expecting a loss of 1.338 to 1.756 billion yuan, and China National Aviation forecasting a loss of 1.7 to 2.2 billion yuan [6][8]. - In contrast, Huaxia Airlines anticipates a net profit of 220 to 290 million yuan, reflecting a year-on-year increase of 741% to 1009% [9]. Group 4: Market Recovery and Future Outlook - The international flight recovery remains slow, with only 84% of pre-pandemic levels restored by 2024, and 88% by the first half of 2025, impacting the profitability of major state-owned airlines [8][10]. - The aviation industry is projected to benefit from the "anti-involution" policies, which may stabilize ticket prices and improve revenue management strategies, potentially leading to a recovery in profitability [14][15].

Investment Rating - The industry investment rating is "Positive" [5] Core Viewpoints - The report highlights that the domestic airline industry is currently in a low season, with a modest increase in capacity deployment of 1.1% year-on-year in June, but a decrease of approximately 2.9% compared to May. Demand remains weak, leading airlines to adopt a more restrained approach to capacity deployment [2][10][14] - Eastern Airlines has shown a notable increase in passenger load factor, rising against the trend of other major airlines, indicating a strategic focus on improving load factors [2][30] - The report anticipates that as the peak summer travel season approaches, operational pressures on the industry are expected to improve, with potential for higher ticket prices due to increased load factors [3][11][38] Summary by Sections 1. Domestic Route Capacity Deployment - In June, listed companies increased domestic route capacity by 1.1% year-on-year, but saw a decrease of about 2.9% month-on-month. Major airlines like Eastern Airlines and Air China reduced capacity by 5.1% and 4.3% respectively compared to May [2][14][16] - The overall passenger load factor for listed companies decreased by 0.4 percentage points month-on-month but increased by approximately 1.7 percentage points year-on-year. Eastern Airlines' load factor continued to rise, reflecting its prioritization of this metric in sales strategies [30][38] 2. International Route Capacity Deployment - International route capacity for listed airlines increased by about 17.4% year-on-year in June, but decreased by 1.5% compared to May. The demand growth for international routes appears to be slowing [3][55] - The passenger load factor for international routes improved by 0.9 percentage points month-on-month and by 1.0 percentage point year-on-year, indicating a slight recovery despite ongoing demand pressures [3][55] 3. Airport Throughput - Major airports such as Shanghai and Shenzhen reported year-on-year growth in international passenger throughput of 17% and 19% respectively. However, there has been a recent slowdown in growth, with some airports experiencing a decline in international passenger numbers over the past two months [68][70]

Core Viewpoint - The three major Chinese airlines (Air China, China Eastern Airlines, and China Southern Airlines) are expected to report significant reductions in net losses for the first half of 2025, but the overall performance remains uneven compared to international counterparts like Delta Airlines, highlighting a complex recovery landscape in the domestic aviation market [1][2]. Group 1: Financial Performance - Air China anticipates a net loss of between 17 billion to 22 billion yuan, with a non-recurring net loss of 18 billion to 24 billion yuan, showing improvement from a net loss of 27.82 billion yuan in the same period of 2024 [2]. - China Eastern Airlines expects a net loss of 12 billion to 16 billion yuan, with a non-recurring net loss of 16 billion to 21 billion yuan, down from a net loss of 27.68 billion yuan year-on-year [2]. - China Southern Airlines projects a net loss of 13.38 billion to 17.56 billion yuan, with a non-recurring net loss of 17.54 billion to 23.80 billion yuan, although its net loss is slightly higher than the previous year's 12.28 billion yuan [2]. Group 2: Factors Influencing Performance - The reduction in losses for the three major airlines is attributed to various strategies, including improved aircraft utilization, marketing strategies, and cost control measures [2]. - The airlines face challenges from high-speed rail competition on short-haul routes and insufficient ticket revenue, despite passenger volumes recovering to or exceeding 2019 levels [3][6]. - Hainan Airlines is expected to achieve a net profit of 45 million to 65 million yuan, indicating successful capacity adjustments and refined management compared to the larger airlines [3]. Group 3: Market Trends and Expectations - The civil aviation industry in China has shown significant recovery momentum, with passenger transport volume reaching 370 million in the first half of 2025, a 5.9% increase year-on-year [4]. - During the summer travel season, passenger transport volume is expected to reach 150 million, reflecting a 5.4% year-on-year growth [4]. - Despite the recovery, the average ticket price for domestic routes has decreased by 7.1%, indicating ongoing challenges in profitability for airlines [5]. Group 4: Future Outlook - The outlook for the second half of 2025 suggests that the three major airlines may further reduce losses, supported by declining fuel costs and a surge in outbound travel demand [4]. - However, the recovery path is complicated by factors such as consumer travel willingness, weather conditions, and ongoing competition from high-speed rail [6].

Core Insights - The company reported an increase in passenger turnover (measured in revenue passenger kilometers) by 3.9% year-on-year, with a capacity increase of 2.5% in available seat kilometers [1][2] - Domestic passenger capacity decreased by 0.2%, while international capacity increased by 9.9%, leading to a 1.4% increase in domestic passenger turnover and an 11.1% increase in international passenger turnover [1][2] - The average passenger load factor improved to 81.1%, up by 1.1 percentage points year-on-year, with increases across domestic, international, and regional routes [1][2] Capacity and Performance - Domestic route capacity was 2,230.8 million available seat kilometers, down 0.9% year-on-year, while international routes saw a capacity of 1,286.0 million, up 10.2% [2] - The total passenger turnover for domestic routes was 1,613.0 million, reflecting a 2.2% increase, while international routes achieved 876.0 million, a 9.4% increase [2] - Cargo capacity increased by 3.6%, with cargo turnover rising by 6.8%, resulting in a cargo load factor of 45.7% [1] Fleet Information - As of June 2025, the company operates a total of 934 aircraft, including 415 owned, 224 under finance leases, and 295 under operating leases [1]